![](/img/cover-not-exists.png)
ODAC Decides All Thumbs Way Down for Abraxane Because Sponsor Requests to Omit Randomized Trial
Fromer, Margot J.Volume:
28
Language:
english
Journal:
Oncology Times
DOI:
10.1097/01.cot.0000303889.15497.94
Date:
September, 2006
File:
PDF, 73 KB
english, 2006